These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 11802750

  • 1. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
    Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B, NSAID-Associated Gastric Ulcer Prevention Study Group.
    Arch Intern Med; 2002 Jan 28; 162(2):169-75. PubMed ID: 11802750
    [Abstract] [Full Text] [Related]

  • 2. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 28; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 3. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM.
    Arch Intern Med; 2000 May 22; 160(10):1455-61. PubMed ID: 10826458
    [Abstract] [Full Text] [Related]

  • 4. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY.
    Am J Med; 2001 Jan 08; 110(1A):58S-61S. PubMed ID: 11166000
    [Abstract] [Full Text] [Related]

  • 5. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.
    Weaver AL, Gitlin N.
    Arch Intern Med; 2002 Oct 28; 162(19):2248-9. PubMed ID: 12390074
    [No Abstract] [Full Text] [Related]

  • 6. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ, Karrasch JA, Szczepañski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND.
    N Engl J Med; 1998 Mar 12; 338(11):727-34. PubMed ID: 9494149
    [Abstract] [Full Text] [Related]

  • 7. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
    Sugano K, Kontani T, Katsuo S, Takei Y, Sakaki N, Ashida K, Mizokami Y, Asaka M, Matsui S, Kanto T, Soen S, Takeuchi T, Hiraishi H, Hiramatsu N.
    J Gastroenterol; 2012 May 12; 47(5):540-52. PubMed ID: 22388884
    [Abstract] [Full Text] [Related]

  • 8. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep 12; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

  • 9. [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
    Hashiguchi M, Yamauchi N, Uchikura T, Mochizuki M.
    Yakugaku Zasshi; 2008 Apr 12; 128(4):585-94. PubMed ID: 18379175
    [Abstract] [Full Text] [Related]

  • 10. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 12; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
    Bianchi Porro G, Lazzaroni M, Imbesi V, Montrone F, Santagada T.
    Dig Liver Dis; 2000 Apr 12; 32(3):201-8. PubMed ID: 10975769
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing.
    Matsukawa Y, Tomita Y, Nishinarita S, Horie T, Kato K, Arakawa Y, Ko K, Shimada H, Nakano M, Kitami Y, Kurosaka H.
    J Int Med Res; 1997 Apr 12; 25(4):190-5. PubMed ID: 9283991
    [Abstract] [Full Text] [Related]

  • 13. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
    Lai KC, Lam SK, Chu KM, Wong BC, Hui WM, Hu WH, Lau GK, Wong WM, Yuen MF, Chan AO, Lai CL, Wong J.
    N Engl J Med; 2002 Jun 27; 346(26):2033-8. PubMed ID: 12087138
    [Abstract] [Full Text] [Related]

  • 14. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.
    Kovacs TO, Campbell D, Haber M, Rose P, Jennings DE, Richter J.
    Dig Dis Sci; 1998 Apr 27; 43(4):779-85. PubMed ID: 9558034
    [Abstract] [Full Text] [Related]

  • 15. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW.
    Am J Health Syst Pharm; 1999 Dec 01; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [Abstract] [Full Text] [Related]

  • 16. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
    Graham DY.
    Helicobacter; 2002 Feb 01; 7(1):1-8. PubMed ID: 11886469
    [Abstract] [Full Text] [Related]

  • 17. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
    Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB, Stanton DS.
    Ann Intern Med; 1995 Sep 01; 123(5):344-50. PubMed ID: 7625622
    [Abstract] [Full Text] [Related]

  • 18. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Taha AS, McCloskey C, McSkimming P, McConnachie A.
    Lancet Gastroenterol Hepatol; 2018 Jul 01; 3(7):469-476. PubMed ID: 29754836
    [Abstract] [Full Text] [Related]

  • 19. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.
    Naesdal J, Wilson I.
    Eur J Gastroenterol Hepatol; 2001 Dec 01; 13(12):1401-6. PubMed ID: 11742186
    [Abstract] [Full Text] [Related]

  • 20. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group.
    Graham DY, White RH, Moreland LW, Schubert TT, Katz R, Jaszewski R, Tindall E, Triadafilopoulos G, Stromatt SC, Teoh LS.
    Ann Intern Med; 1993 Aug 15; 119(4):257-62. PubMed ID: 8328732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.